Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Moderna Chalks Up Industry Milestone With mRNA Cancer Vaccine Efficacy Success

Dec 14 2022

• By Joseph Haas

Moderna — Moderna gets key data for its personalized cancer vaccine • Source: Shutterstock

Related Content

Merck Bets Moderna's Cancer Vaccines Can Prime Patients For Immunotherapy

Jun 29 2016

CMO Eliav Barr On Merck & Co.'s Post-Keytruda Game Plan

Nov 25 2022

Moderna Highlights Near-Term Non-COVID Readouts As Pandemic Vaccine Sales Drop

Nov 03 2022

Merck & Co. Pounces On Moderna mRNA-Based Cancer Vaccine Option

Oct 12 2022

Related Companies

Moderna, Inc.

Merck & Co., Inc.

Pfizer Inc.

BioNTech SE

Additional Topics

Clinical Trials Business Strategies Innovation ImmunoOncology Research & Development BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window